STADA Acquires FITO Trademark from LEO Pharma and Expands Consumer Healthcare in the MENA Region

latestmiscellaneous newsCommunityMain News
By:
On:

The pharmaceutical company STADA is expanding its consumer healthcare business in the MENA region with the acquisition of FITO™ from LEO Pharma. The medical device is based on the wheat extract Rigenase (Damor Farmaceutici, Italy) and is indicated for the dermatological treatment of first- and second-degree burns, ulcers, wounds andContinue Reading